MILANOVA TSVETA

PrivateCIK: 1957180
Location

CAMBRIDGE, MA

MILANOVA TSVETA (Chief Commercial Officer) sold 6.5% of their position (2.87K shares) of AGIOS PHARMACEUTICALS, INC. on the open market

Open‑market sale worth $83.1K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 2 sales
InsiderMILANOVA TSVETACIK 1957180
Officer· Chief Commercial Officer
Since Mar 2026
+63.13K
Net shares
Net buyer
$83.1K
Total sold
2
Open market trades
0B · 2S
8
Total transactions
75.67K acquired · 12.53K disposed
Non-Derivative Transactions4

Common stock

Direct
M · Option Exercise

Shares

+5.67K

Price / share

Trade value

% of position

16.3%
3/2/2026
34.79K40.46K

Common stock

Direct
S · Sale

Shares

1.68K

Price / share

$28.96

Trade value

$48.68K

% of position

4.2%
3/2/2026
40.46K38.78K

Common stock

Direct
M · Option Exercise

Shares

+4K

Price / share

Trade value

% of position

10.3%
3/2/2026
38.78K42.78K

Common stock

Direct
S · Sale

Shares

1.19K

Price / share

$28.96

Trade value

$34.38K

% of position

2.8%
3/2/2026
42.78K41.59K
Total

Net shares

+6.80K

Net value

-$83.06K

Derivative Transactions4

Restricted stock units

Direct
A · Award
Converts to

Common stock

14K shares

Shares

+14K

Strike price

Held after

14K

Exercisable

3/1/2026

Stock options (right to buy)

Direct
A · Award
Converts to

Common stock

52K shares

Shares

+52K

Strike price

30.23

Held after

52K

Exercisable

3/1/2026

Restricted stock units

Direct
M · Option Exercise
Converts to

Common stock

5.67K shares

Shares

5.67K

Strike price

Held after

5.67K

Exercisable

3/2/2026

Restricted stock units

Direct
M · Option Exercise
Converts to

Common stock

4K shares

Shares

4K

Strike price

Held after

8K

Exercisable

3/2/2026
MILANOVA TSVETA — Insider Transaction (Form 4) Filed Mar 3, 2026 | Finecho